Tivic Health terminates ALOM fulfillment agreement to reduce costs, transitions to in-house ops

Valion Bio, Inc.

Effective August 1, 2024, terminated ALOM Fulfillment Services Agreement for convenience; no material early termination penalties.
Transitioned to alternate third-party logistics and in-house assembly/testing; no service disruption and capacity sufficient for foreseeable demand.
Minimum monthly purchase requirement of $25,000 was waived from January through June 2024 prior to termination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.